Adam Stoller, MD
Anesthesiology · Weymouth, MANPI 1699913178
Payments from drug & device makers
Across 209 payments — averaging $28.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$618
- Stimwave Technologies Incorporated$316
- Collegium Pharmaceutical, Inc.$263
- AbbVie$229
- Electronic Waveform Lab, Inc.$161
- plus $2K from 31 others
What the payments were for
- Travel & lodging$57210%
- Food & beverage$5,04985%
- Education$3115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 68 | $2,802 |
| Boston Scientific | 30 | $618 |
| Stimwave Technologies Incorporated | 8 | $316 |
| Collegium Pharmaceutical, Inc. | 13 | $263 |
| AbbVie(2 entities) | 12 | $229 |
| Electronic Waveform Lab, Inc. | 10 | $161 |
| Relievant Medsystems, Inc. | 2 | $158 |
| Biodelivery Sciences International, Inc. | 7 | $124 |
| Teva Pharmaceuticals USA, Inc. | 5 | $118 |
| MML US, Inc. | 3 | $98 |
| Nevro Corp. | 4 | $86 |
| Scilex Pharmaceuticals Inc. | 4 | $85 |
| Amgen(2 entities) | 4 | $78 |
| MDD US Operations, LLC | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 2 | $64 |
| Stryker | 1 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Vertex | 2 | $59 |
| Novartis | 4 | $56 |
| SPR Therapeutics, Inc | 2 | $49 |
| Saluda Medical Americas, Inc. | 2 | $47 |
| Pfizer | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Almatica Pharma LLC | 1 | $28 |
| Johnson & Johnson | 2 | $26 |
| Convatec Inc. | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Flowonix Medical Incorporated | 1 | $23 |
| Nalu Medical, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $19 |
| Si-bone, Inc. | 1 | $16 |
| Kaleo, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Forte Bio-pharma LLC | 1 | $13 |
| Shionogi Inc | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$667
- Proclaim IPG$311
- Intracept$128
How this compares
$5,932 in reported general payments places this provider in the 90th percentile of 1,585 anesthesiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 21 | $42,614 |
| RelistorMethylnaltrexone Bromide | 12 | $9,210 |
| ButransBuprenorphine | 11 | $5,971 |
| Buprenorphine | 22 | $4,439 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 134 | $3,340 |
| Gabapentin | 59 | $1,577 |
| Pregabalin | 57 | $856 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $652 |
| Oxycodone Hcl | 17 | $579 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $427 |
| Baclofen | 16 | $332 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $232 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $217 |
| Duloxetine Hcl | 25 | $179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $263 | $42,61421 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $61 | $9,21012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,585 anesthesiology providers in Massachusetts.
Other anesthesiology in Weymouth
- Xiaodong BaoMethuen$1.4M
- Balachundhar SubramaniamLexington$747K
- Srdjan NedeljkovicBrighton$702K
- Mathias EikermannBoston$461K
- Robert YongBoston$459K
- Lorenzo BerraBoston$437K
- Timothy DelsolBoston$389K
- James StreisandCambridge$380K
- Edgar RossBoston$377K
- Hisham ElkadiMelrose$375K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.